<DOC>
	<DOCNO>NCT01433380</DOCNO>
	<brief_summary>The primary purpose study evaluate pharmacodynamics single oral dos PF-05175157 healthy volunteer</brief_summary>
	<brief_title>A Study To Evaluate PF-05175157 In Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Healthy male and/or female subject age 18 55 year , inclusive . Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 lead ECG clinical laboratory test . In addition , subject must normal pulmonary function test normal ocular examination . Body Mass Index 20.0 35.0 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Evidence history clinically significant hematological , renal , endocrine , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Evidence history chronic ongoing current pulmonary disease . History smoke past 5 year history evidence habitual use ( non smoke ) tobacco nicotinecontaining product within 3 month Screening positive cotinine test Screening Day 0 . Active ocular disease include infection , glaucoma , seasonal allergy , dry eye symptom retinal/optic nerve disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Single Doses</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Healthy Volunteers</keyword>
</DOC>